Chris Springer

Verified profile

Venture Capital, Private Equity Firm, Angel/Individual · United States

Chris Springer is a venture capital investor and private equity investor based in the United States. They invest in Transportation, Chemical, Banking and Information Technology (IT), typically at the Early Stage Venture stage. Their portfolio includes Hyperloop Transportation Technologies.

Investment stages

Industries

Portfolio companies (1)

  • Hyperloop Transportation Technologies

Similar investors in Transportation

  • Stacey Olson

    Venture Capital · United States

    Health CareWomen FoundedEnterprise SoftwareTransportation

    Portfolio: FreightWeb, Motherly

    Contact details available

  • Thomas Parkinson

    Venture Capital, Government Office, Private Equity Firm · United States

    Health CareTelecommunicationsAutonomous VehiclesCybersecurity

    Portfolio: Adrenaline Mobility, EarthSense, Inc.

    Contact details available

  • Barron De Sanctis

    Angel/Individual · United States

    SeedData IntegrationFleet ManagementTransportationCloud Computing

    Portfolio: LeaseUp, Zeros

    Contact details available

  • Alex KaufmanVerified

    Venture Capital, Investor · United States

    SeedSeries AData IntegrationAutonomous VehiclesCybersecurityLeisure

    Portfolio: Node, Betterez

    Contact details available

  • Andy Flaster

    Venture Capital, Investor · United States

    Series BHealth CareTelecommunicationsAutonomous VehiclesE-commerce

    Portfolio: Prinova, Xoom

    Contact details available

  • Arnaud De Vos

    Venture Capital · United States

    Health CareData IntegrationAccountingCybersecurity

    Portfolio: Cabovisão, MobileXpense

    Contact details available

  • Tyler Kramp

    Venture Debt · United States

    TransportationAutomotiveManufacturing

    Portfolio: Compass Automotive Group

    Contact details available

  • Bob Adelson

    Venture Capital · United States

    Health CareTelecommunicationsWellnessWomen Founded

    Portfolio: InstaMed, Earnest Research

    Contact details available